JPWO2021141969A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021141969A5 JPWO2021141969A5 JP2022542118A JP2022542118A JPWO2021141969A5 JP WO2021141969 A5 JPWO2021141969 A5 JP WO2021141969A5 JP 2022542118 A JP2022542118 A JP 2022542118A JP 2022542118 A JP2022542118 A JP 2022542118A JP WO2021141969 A5 JPWO2021141969 A5 JP WO2021141969A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl groups
- independently
- compound according
- alkyl
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025160231A JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062958876P | 2020-01-09 | 2020-01-09 | |
| US62/958,876 | 2020-01-09 | ||
| PCT/US2021/012282 WO2021141969A1 (en) | 2020-01-09 | 2021-01-06 | Nanomaterials |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025160231A Division JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023510778A JP2023510778A (ja) | 2023-03-15 |
| JPWO2021141969A5 true JPWO2021141969A5 (https=) | 2024-01-17 |
| JP2023510778A5 JP2023510778A5 (https=) | 2024-01-17 |
| JP7791822B2 JP7791822B2 (ja) | 2025-12-24 |
Family
ID=76788721
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542118A Active JP7791822B2 (ja) | 2020-01-09 | 2021-01-06 | ナノマテリアル |
| JP2025160231A Pending JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025160231A Pending JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12435035B2 (https=) |
| EP (1) | EP4103542A4 (https=) |
| JP (2) | JP7791822B2 (https=) |
| KR (1) | KR20220123536A (https=) |
| CN (2) | CN119684140A (https=) |
| AU (1) | AU2021205837A1 (https=) |
| BR (1) | BR112022013599A2 (https=) |
| CA (1) | CA3163161A1 (https=) |
| IL (1) | IL294318A (https=) |
| MX (1) | MX2022008455A (https=) |
| WO (1) | WO2021141969A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12569438B2 (en) | 2019-07-29 | 2026-03-10 | Georgia Tech Research Corporation | Nanomaterials containing constrained lipids and uses thereof |
| US12435035B2 (en) | 2020-01-09 | 2025-10-07 | Guide Therapeutics, Llc | Nanomaterials |
| US12594519B2 (en) | 2020-07-15 | 2026-04-07 | W. L. Gore & Associates, Inc. | Methods for regenerating a filter medium and cleaning flue gas |
| JP2023549011A (ja) | 2020-09-15 | 2023-11-22 | ヴァーヴ・セラピューティクス，インコーポレーテッド | 遺伝子編集のための脂質製剤 |
| JP2023546175A (ja) | 2020-10-14 | 2023-11-01 | ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド | 脂質ナノ粒子製造の方法及びそれに由来する組成物 |
| MX2023007137A (es) * | 2020-12-21 | 2023-08-28 | Beam Therapeutics Inc | Nanomateriales que comprenden acetales unidos a ésteres. |
| IL303845A (en) * | 2021-01-20 | 2023-08-01 | Beam Therapeutics Inc | Nanomaterials include a degradable property |
| KR20230131863A (ko) | 2021-01-20 | 2023-09-14 | 빔 테라퓨틱스, 인크. | 나노물질 |
| US20240180954A1 (en) * | 2021-02-04 | 2024-06-06 | Shionogi & Co., Ltd. | Cationic lipid |
| CA3234127A1 (en) * | 2021-10-08 | 2023-04-13 | Suzhou Abogen Biosciences Co., Ltd. | Lipid compounds and lipid nanoparticle compositions |
| CN118829624A (zh) * | 2022-01-17 | 2024-10-22 | 赛诺菲 | 脂质化合物及其用途 |
| EP4532713A1 (en) | 2022-05-27 | 2025-04-09 | Beam Therapeutics Inc. | Identification of nanoparticles for preferential tissue or cell targeting |
| WO2024019936A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
| WO2024199282A1 (zh) * | 2023-03-28 | 2024-10-03 | 苏州艾博生物科技有限公司 | 脂质化合物和脂质纳米颗粒组合物 |
| US12311033B2 (en) | 2023-05-31 | 2025-05-27 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025038864A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Ionizable lipids with linear head groups |
| CN119490447A (zh) * | 2023-08-17 | 2025-02-21 | 苏州星核迪赛生物技术有限公司 | 药物递送材料及其应用 |
| WO2025166314A1 (en) * | 2024-02-02 | 2025-08-07 | Tessera Therapeutics, Inc. | Ex vivo delivery of lipid nanoparticles for delivery of gene modifying systems to t cells |
| WO2025212851A2 (en) | 2024-04-03 | 2025-10-09 | Orbital Therapeutics, Inc. | mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES |
| WO2025259931A1 (en) | 2024-06-14 | 2025-12-18 | Orbital Therapeutics, Inc. | Compositions and methods for rna circularization |
| WO2026006203A2 (en) | 2024-06-24 | 2026-01-02 | Orbital Therapeutics, Inc. | Compositions and methods for making circular rna |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026006687A1 (en) | 2024-06-28 | 2026-01-02 | Orbital Therapeutics, Inc. | Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL257307A (https=) | 1959-10-28 | |||
| US3686238A (en) | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| US20030083272A1 (en) | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| US6670499B1 (en) | 1999-11-08 | 2003-12-30 | Daicel Chemical Industries, Ltd. | Adamantane derivatives and processes for the preparation thereof |
| US20040259247A1 (en) | 2000-12-01 | 2004-12-23 | Thomas Tuschl | Rna interference mediating small rna molecules |
| WO2003101952A2 (en) | 2002-05-31 | 2003-12-11 | The Regents Of The University Of California | Polyamine-mediated transfection |
| JP2005181734A (ja) | 2003-12-19 | 2005-07-07 | Fuji Photo Film Co Ltd | 画像記録材料 |
| DE102007029471A1 (de) | 2007-06-20 | 2008-12-24 | Novosom Ag | Neue fakultativ kationische Sterole |
| AU2009238175C1 (en) | 2008-04-15 | 2023-11-30 | Arbutus Biopharma Corporation | Novel lipid formulations for nucleic acid delivery |
| SG186085A1 (en) | 2010-06-03 | 2013-01-30 | Alnylam Pharmaceuticals Inc | Biodegradable lipids for the delivery of active agents |
| KR102451116B1 (ko) | 2011-10-27 | 2022-10-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | 약물 캡슐화 마이크로스피어를 형성할 수 있는, ｎ-말단 상에 관능화된 아미노산 유도체 |
| EP2788006B1 (en) | 2011-12-07 | 2026-01-07 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| EP3608308B1 (en) | 2013-03-08 | 2021-07-21 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP4019506A1 (en) | 2013-12-19 | 2022-06-29 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| ES2895651T3 (es) | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| DK3297637T3 (da) | 2015-05-21 | 2021-08-02 | Ohio State Innovation Foundation | Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf |
| EP4286012A3 (en) | 2015-09-17 | 2024-05-29 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| JP7109784B2 (ja) | 2015-10-23 | 2022-08-01 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 遺伝子編集のための進化したＣａｓ９蛋白質 |
| IL307179A (en) | 2015-10-28 | 2023-11-01 | Acuitas Therapeutics Inc | Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| TWI773666B (zh) | 2016-03-30 | 2022-08-11 | 美商英特利亞醫療公司 | Crispr/cas 組分之脂質奈米粒子調配物 |
| MY206271A (en) | 2016-07-11 | 2024-12-06 | Opko Biologics Ltd | Long-acting coagulation factor vii and methods of producing same |
| KR102547316B1 (ko) | 2016-08-03 | 2023-06-23 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 아데노신 핵염기 편집제 및 그의 용도 |
| SMT202300097T1 (it) * | 2017-03-15 | 2023-05-12 | Modernatx Inc | Composto e composizioni per il rilascio intracellulare di agenti terapeutici |
| EP3630076A1 (en) | 2017-05-30 | 2020-04-08 | GlaxoSmithKline Biologicals SA | Methods for manufacturing a liposome encapsulated rna |
| WO2019008441A1 (en) | 2017-07-04 | 2019-01-10 | Intocell, Inc. | COMPOUNDS COMPRISING A CLIABABLE BIT AND USES THEREOF |
| EP3704262B1 (en) | 2017-10-30 | 2024-03-20 | Georgia Tech Research Corporation | Multiplexed analysis of materials for tissue delivery |
| WO2019099501A1 (en) | 2017-11-14 | 2019-05-23 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof |
| EP3727362A4 (en) | 2017-12-19 | 2021-10-06 | PureTech LYT, Inc. | MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES |
| MX2020006843A (es) | 2017-12-27 | 2020-09-03 | Takeda Pharmaceuticals Co | Nanoparticula de lipido que contiene acido nucleico y uso de la misma. |
| CN112955099B (zh) | 2018-07-27 | 2024-04-26 | 雷森斯医疗有限公司 | 医疗冷却装置和使用其的冷却方法 |
| US20210300962A1 (en) | 2018-08-02 | 2021-09-30 | Puretech Lyt, Inc. | Lipid prodrugs of pregnane neurosteroids and uses thereof |
| JP7436990B2 (ja) | 2018-08-10 | 2024-02-22 | 国立大学法人京都大学 | カチオン性脂質を用いた心筋細胞へのトランスフェクション方法 |
| WO2020072605A1 (en) | 2018-10-02 | 2020-04-09 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| IL314386A (en) | 2018-12-05 | 2024-09-01 | Intellia Therapeutics Inc | amine modified lipids |
| JP7636330B2 (ja) | 2019-01-17 | 2025-02-26 | ジョージア テック リサーチ コーポレイション | 酸化コレステロールを含有する薬物送達システム |
| WO2020152037A1 (en) | 2019-01-24 | 2020-07-30 | Agfa Nv | Radiation curable inkjet inks for interior decoration |
| KR20210139265A (ko) | 2019-02-13 | 2021-11-22 | 빔 테라퓨틱스, 인크. | 표적 서열에서 핵염기를 변형하기 위한 아데노신 데아미나제 염기 편집기 및 이의 사용 방법 |
| WO2020176856A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of glucocorticoids and uses thereof |
| WO2020176868A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of btk inhibitors and uses thereof |
| US12594339B2 (en) | 2019-02-28 | 2026-04-07 | Seaport Therapeutics, Inc. | Lipid prodrugs of JAK inhibitors and uses thereof |
| WO2020219876A1 (en) * | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| CN114144173A (zh) | 2019-06-05 | 2022-03-04 | 盖德治疗公司 | 用于组织递送的材料的分析 |
| WO2020246581A1 (ja) | 2019-06-07 | 2020-12-10 | 富士フイルム株式会社 | 脂質組成物 |
| US12569438B2 (en) | 2019-07-29 | 2026-03-10 | Georgia Tech Research Corporation | Nanomaterials containing constrained lipids and uses thereof |
| US20220259597A1 (en) | 2019-07-29 | 2022-08-18 | Georgia Tech Research Corporation | Oligonucleotide antagonists for rna guided genome editing |
| MX2022004760A (es) | 2019-10-21 | 2022-07-21 | Flaskworks Llc | Sistemas y métodos para el cultivo de células. |
| JP7699128B2 (ja) | 2019-12-06 | 2025-06-26 | ガイド セラピューティクス，エルエルシー | ナノマテリアル |
| US12435035B2 (en) | 2020-01-09 | 2025-10-07 | Guide Therapeutics, Llc | Nanomaterials |
| WO2022140239A1 (en) | 2020-12-21 | 2022-06-30 | Beam Therapeutics Inc. | Nanomaterials comprising carbonates |
| MX2023007137A (es) | 2020-12-21 | 2023-08-28 | Beam Therapeutics Inc | Nanomateriales que comprenden acetales unidos a ésteres. |
| CN116782913A (zh) | 2020-12-21 | 2023-09-19 | 比姆医疗股份有限公司 | 包括缩醛的纳米材料 |
| KR20230131863A (ko) | 2021-01-20 | 2023-09-14 | 빔 테라퓨틱스, 인크. | 나노물질 |
| JP2024503441A (ja) | 2021-01-20 | 2024-01-25 | ビーム セラピューティクス インク． | イオン化可能な脂質を含むナノ材料 |
| IL303845A (en) | 2021-01-20 | 2023-08-01 | Beam Therapeutics Inc | Nanomaterials include a degradable property |
| AU2022210299A1 (en) | 2021-01-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable lipids for nanomaterials |
| WO2022251665A1 (en) | 2021-05-28 | 2022-12-01 | Renagade Therapeutics Management Inc. | Lipid nanoparticles and methods of use thereof |
| CA3234127A1 (en) | 2021-10-08 | 2023-04-13 | Suzhou Abogen Biosciences Co., Ltd. | Lipid compounds and lipid nanoparticle compositions |
| EP4452930A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Ionizable amine and ester lipids and lipid nanoparticles |
| CA3241488A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine lipids and lipid nanoparticles |
| EP4452925A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Nanomaterial comprising diamines |
| EP4452942A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
| WO2023121971A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising tetravalent lipid compounds |
| WO2024019936A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
-
2021
- 2021-01-06 US US17/142,595 patent/US12435035B2/en active Active
- 2021-01-06 MX MX2022008455A patent/MX2022008455A/es unknown
- 2021-01-06 EP EP21738179.7A patent/EP4103542A4/en active Pending
- 2021-01-06 CN CN202411119983.0A patent/CN119684140A/zh active Pending
- 2021-01-06 BR BR112022013599A patent/BR112022013599A2/pt unknown
- 2021-01-06 WO PCT/US2021/012282 patent/WO2021141969A1/en not_active Ceased
- 2021-01-06 CA CA3163161A patent/CA3163161A1/en active Pending
- 2021-01-06 KR KR1020227026151A patent/KR20220123536A/ko not_active Ceased
- 2021-01-06 CN CN202180016840.5A patent/CN115175894B/zh active Active
- 2021-01-06 IL IL294318A patent/IL294318A/en unknown
- 2021-01-06 AU AU2021205837A patent/AU2021205837A1/en active Pending
- 2021-01-06 JP JP2022542118A patent/JP7791822B2/ja active Active
-
2025
- 2025-09-03 US US19/317,946 patent/US20260001838A1/en active Pending
- 2025-09-26 JP JP2025160231A patent/JP2026016394A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021141969A5 (https=) | ||
| JP2025181861A5 (https=) | ||
| CN104004018B (zh) | 具有含氮脂环式骨架的单链核酸分子 | |
| AU2022202140B2 (en) | Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids | |
| CN102918156B (zh) | 用于控制基因表达的单链核酸分子 | |
| US9962449B2 (en) | MultiLigand agent for drug delivery | |
| JP7748500B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| CN110678447B (zh) | 经修饰的核酸单体化合物及寡核酸类似物 | |
| CA2767129A1 (en) | Compositions and methods for silencing apolipoprotein b | |
| JPWO2021113365A5 (https=) | ||
| CA3187220A1 (en) | Systemic delivery of oligonucleotides | |
| JP2012509273A5 (https=) | ||
| CN118076621A (zh) | 多羟基化的环戊烷衍生物及使用方法 | |
| AU2023224208A1 (en) | 5'-modified carbocyclic ribonucleotide derivatives and methods of use | |
| CN116615542A (zh) | 寡核苷酸的全身递送 | |
| KR20220004675A (ko) | 단축 센스 가닥을 갖는 이중 가닥 핵산 억제제 분자 | |
| JP2023063434A (ja) | オリゴヌクレオチド誘導体またはその塩 | |
| JP7820060B2 (ja) | 分子の膜貫通送達のための化合物および方法 | |
| TWI871840B (zh) | 合成4'-磷酸鹽類似物核苷酸亞磷醯胺之方法 | |
| CN120398741A (zh) | 一种用于递送核酸物质的脂肪酸衍生物及其合成方法 | |
| KR20260042246A (ko) | 다가 카고 함유 복합체 및 이의 용도 | |
| RU2026104839A (ru) | Мультивалентные комплексы, несущие полезную нагрузку, и их применение | |
| CN119421887A (zh) | 环膦酸酯修饰的核苷酸 | |
| HK1200460B (en) | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | |
| HK1181423B (en) | Single-strand nucleic acid molecule for controlling gene expression |